Koyfin Home > Directory > Health Care > Amicus Therapeutics > Net Income Margin

Amicus Therapeutics Net Income Margin Chart (FOLD)

Amicus Therapeutics annual/quarterly Net Income Margin from 2008 to 2018. Net profit margin, or net margin, is equal to net income or profits divided by total revenue and represents how much profit each dollar of sales generates. Net profit margin is the ratio of net profits or net income to revenues for a company.
  • Amicus Therapeutics Net Income Margin for the quarter ending December 12, 2018 was $-239m a 63.28% decrease of -151m year over year
  • Amicus Therapeutics Net Income Margin for the last 12 months ending December 12, 2012 was $-265m a 28.23% decrease of -75m year over year
  • Amicus Therapeutics Annual Net Income Margin for 2012 was $-265m a 21.80% decrease of -58m from 2011
  • Amicus Therapeutics Annual Net Income Margin for 2011 was $-207m a 95.08% decrease of -197m from 2010
  • Amicus Therapeutics Annual Net Income Margin for 2009 was $-10m a -2,476.93% increase of 253m from 2008
Other Margins & Efficiency Metrics:
  • Amicus Therapeutics EBITDA Margin for the quarter ending December 12, 2018 was $-208m a 36.06% decrease of -75m year over year
  • Amicus Therapeutics Return on Capital % for the quarter ending September 09, 2018 was -53.00 a 52.45% decrease of -27.80 year over year
  • Amicus Therapeutics Return on Equity % for the quarter ending September 09, 2018 was -130.88 a 44.52% decrease of -58.28 year over year
View Chart On Koyfin

Quarterly FOLD Net Income Margin Data

12/2018$-239m
06/2018$-290m
03/2018$-299m
06/2012$-88m
03/2012$-169m
12/2011$-154m
09/2011$-168m
03/2011$-224m
12/2009$67m
09/2009$-273m

Annual FOLD Net Income Margin Data

2012$-265m
2011$-207m
2009$-10m
2008$-263m